Insider · CIK 0002028250
Dennis McBride
Files at NRXP (NRX Pharmaceuticals, Inc.). First filing -, latest -.
Dennis McBride files SEC Form 4 as director at NRXP (NRX Pharmaceuticals, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Dennis McBride has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Apr 9, 2025 | NRXP NRX Pharmaceuticals, Inc. | AGrant or award Stock Option (right to buy)derivative | +25,000 | $0.00 | $0 | 25,000 | Sep 10, 2025 |
Questions about Dennis McBride
Answered from the filings on this page, as of the latest one.
Is Dennis McBride buying or selling?
Dennis McBride has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Dennis McBride's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Dennis McBride has 0.
Where does Dennis McBride file Form 4?
Dennis McBride has filed Form 4 at NRXP (NRX Pharmaceuticals, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.